e-learning
resources
London 2016
Sunday, 04.09.2016
Clinical aspects of ILD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The King’s brief interstitial lung disease (K-BILD) questionnaire; an updated minimal important difference
Aish Sinha (London, United Kingdom), Aish Sinha, Amit S. Patel, Richard Siegert, Sabrina Bajwah, Greg Keir, Patrick Gordon, Sophia Steer, Toby M. Maher, Elisabetta A. Renzoni, Athol U. Wells, Irene J. Higginson, Surinder S. Birring
Source:
International Congress 2016 – Clinical aspects of ILD
Session:
Clinical aspects of ILD
Session type:
Thematic Poster
Number:
808
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Aish Sinha (London, United Kingdom), Aish Sinha, Amit S. Patel, Richard Siegert, Sabrina Bajwah, Greg Keir, Patrick Gordon, Sophia Steer, Toby M. Maher, Elisabetta A. Renzoni, Athol U. Wells, Irene J. Higginson, Surinder S. Birring. The King’s brief interstitial lung disease (K-BILD) questionnaire; an updated minimal important difference. Eur Respir J 2016; 48: Suppl. 60, 808
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Related content which might interest you:
Response of the King’s brief interstitial lung disease (KBILD) questionnaire to pulmonary rehabilitation (PR)
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015
Comparison of changes of the King’s brief interstitial lung disease questionnaire (K-BILD) with other health status measures
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016
A comparison of two scoring methods for the King’s brief interstitial lung disease questionnaire
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Quality of life in interstitial lung disease: Utility of the Kings brief interstitial lung disease questionairre at baseline
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Translation and validation of the King's brief interstitial lung disease (K-BILD) questionnaire in French, Italian and Dutch
Source: International Congress 2014 – ILDs 2
Year: 2014
Impact of gender on disease activity, pulmonary function and health status in sarcoidosis patients – King’s sarcoidosis questionnaire (KSQ)
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
A comparison of two scoring methods for the King’s sarcoidosis questionnaire
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Quality of life measures in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
King’s Brief Interstitial Lung Disease (K-BILD) questionnaire: content relevance in progressive fibrosing ILD (PF-ILD)
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Depression and anxiety in pulmonary fibrosis: A pilot study
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Assessment of health related quality of life in interstitial lung diseases (ILD) using the St George‘s Respiratory Questionnaire (SGRQ) and Short Form-36 (SF 36)
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Measuring quality of life and disease progression in interstitial lung disease - a critical appraisal of the St George’s respiratory questionnaire
Source: Annual Congress 2004 - Nurse-managed services and quality of life
Year: 2004
The efficacy of a walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). A pilot study
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Quality of life of idiopathic pulmonary fibrosis patients
Source: Eur Respir J 2001; 17: 954-961
Year: 2001
Association between quality of life as assessed by St. George's respiratory questionnaire (SGRQ), lung function indices and sputum inflammatory parameters in Indian COPD patients
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Health status & impact of living with idiopathic pulmonary fibrosis (IPF): UK & Ireland Delphi survey
Source: International Congress 2016 – IPF clinical
Year: 2016
Discordant symptom severity in COPD: The PHAROAH study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Perception of the disease and its impact on life in lung cancer patients
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
The King‘s brief interstitial lung disease quality of life questionnaire (K-BILD) for patients with IPF and other ILDs
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011
The assessment of the effect of changes in lung cancer follow-up period to the quality of life by using EQ-5D questionnaire and follow data (the project of AKAYAK-1)
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept